Why the study?
A translational lipidomic approach was needed to discover and validate lipid biomarkers that could predict morphometric body and histological organ measurements during specific stages of life.
This protocol provides a translational lipidomic approach to discover and validate lipid biomarkers from animal models to human cohorts.
Protocol enables lipid biomarker discovery across species; leaves open validation for predicting early-life adiposity.
This protocol outlines a translational lipidomic approach to discover lipid biomarkers that could predict morphometric body and histological organ measurements (e.g., weight and adiposity gains) during specific stages of life (e.g., early life). We describe procedures ranging from animal experimentation and histological analyses to downstream analytical steps through lipid profiling, both in mice and humans. This protocol represents a reliable and versatile approach to translate and validate candidate lipid biomarkers from animal models to a human cohort. For complete details on the use and execution of this protocol, please refer to Olga et al. (2021).
No takes yet. Share an insight, caveat, or question.
Olga et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: